Cargando…

COVID-19 and the cost of bond debt: The role of corporate diversification

We examine whether diversification is valuable in reducing the cost of debt for COVID-19-exposed firms. We find that although the pandemic has increased firms’ borrowing costs, both business and geographic diversifications reduce bond yield spreads for COVID-19-exposed firms. This highlights that th...

Descripción completa

Detalles Bibliográficos
Autor principal: Almaghrabi, Khadija S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451396/
https://www.ncbi.nlm.nih.gov/pubmed/34566527
http://dx.doi.org/10.1016/j.frl.2021.102454
_version_ 1784569837201129472
author Almaghrabi, Khadija S.
author_facet Almaghrabi, Khadija S.
author_sort Almaghrabi, Khadija S.
collection PubMed
description We examine whether diversification is valuable in reducing the cost of debt for COVID-19-exposed firms. We find that although the pandemic has increased firms’ borrowing costs, both business and geographic diversifications reduce bond yield spreads for COVID-19-exposed firms. This highlights that the coinsurance features and enhanced investment opportunities of diversified firms are valuable during difficult times. We also find that unrelated diversification and diversification in countries with low COVID-19 uncertainty have a more substantial effect on reducing the bond spreads of COVID-19-exposed firms. These findings are essential for building a complete picture of the effect of COVID-19 on borrowing costs.
format Online
Article
Text
id pubmed-8451396
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-84513962021-09-20 COVID-19 and the cost of bond debt: The role of corporate diversification Almaghrabi, Khadija S. Financ Res Lett Article We examine whether diversification is valuable in reducing the cost of debt for COVID-19-exposed firms. We find that although the pandemic has increased firms’ borrowing costs, both business and geographic diversifications reduce bond yield spreads for COVID-19-exposed firms. This highlights that the coinsurance features and enhanced investment opportunities of diversified firms are valuable during difficult times. We also find that unrelated diversification and diversification in countries with low COVID-19 uncertainty have a more substantial effect on reducing the bond spreads of COVID-19-exposed firms. These findings are essential for building a complete picture of the effect of COVID-19 on borrowing costs. Elsevier Inc. 2022-05 2021-09-15 /pmc/articles/PMC8451396/ /pubmed/34566527 http://dx.doi.org/10.1016/j.frl.2021.102454 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Almaghrabi, Khadija S.
COVID-19 and the cost of bond debt: The role of corporate diversification
title COVID-19 and the cost of bond debt: The role of corporate diversification
title_full COVID-19 and the cost of bond debt: The role of corporate diversification
title_fullStr COVID-19 and the cost of bond debt: The role of corporate diversification
title_full_unstemmed COVID-19 and the cost of bond debt: The role of corporate diversification
title_short COVID-19 and the cost of bond debt: The role of corporate diversification
title_sort covid-19 and the cost of bond debt: the role of corporate diversification
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451396/
https://www.ncbi.nlm.nih.gov/pubmed/34566527
http://dx.doi.org/10.1016/j.frl.2021.102454
work_keys_str_mv AT almaghrabikhadijas covid19andthecostofbonddebttheroleofcorporatediversification